Skip to content

Echocardiographic Measurement of Myocardial Work

Non-invasive Measurement of Myocardial Work Using Transthoracic Echocardiography in Critically Ill Patients: the MYOLOAD Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06422481
Acronym
MYOLOAD
Enrollment
110
Registered
2024-05-21
Start date
2024-07-31
Completion date
2025-12-31
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Physiological Phenomena, Intensive Care Unit Syndrome

Brief summary

Echocardiography is recommended for the hemodynamic management of patients with shock. Recently, a new echocardiographic method has been proposed that provides a non-invasive measurement of myocardial work incorporating different components, namely total myocardial work (GWI), constructive myocardial work (GCW), lost myocardial work (GWW) and effective myocardial work (GWE). Echocardiographic measurement of myocardial work takes into account both myocardial deformation and left ventricular afterload (estimated by measuring systolic blood pressure) and, unlike the measurement of left ventricular ejection fraction and global longitudinal strain, could be less dependent on cardiac load conditions, particularly left ventricular afterload. To date, non-invasive measurement of myocardial work has never been validated in critically ill patients, and no study has assessed the effects of different therapies (fluids administration, administration of norepinephrine) on the different components of myocardial work in patients admitted to intensive care unit.

Interventions

Patients will receive fluid administration (500 mL of saline over 30 minutes). The indication of fluid administration will be left to the discretion of the attending physician.

OTHERNorepinephrine administration or increase in norepinephrine dosage

Patients will receive norepinephrine or norepinephrine dosage will be increased if necessary to achieve the appropriate mean arterial pressure level. The indication of norepinephrine administration or increase in norepinephrine dosage will be left to the discretion of the attending physician.

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Indication to fluid administration left to the discretion of the attending physician * Indication to norepinephrine administration or increase in norepinephrine dosage left to the discretion of the attending physician.

Exclusion criteria

* Patients under protection. * Patients with do not ressuscitate order. * Patients with severe left-side or right-side valvulopathy. * Patients with atrial fibrillation. * Patients with ventricular aneuvrysm or severe regional wall motion abnormalities. * Patients with a pacemaker. * Patients' objections to the collection of their health data.

Design outcomes

Primary

MeasureTime frameDescription
Determine the feasibility of echocardiographic measurementthrough study completion, an average of 1 yearThe primary outcome will be assess by evaluating the proportion of patients in whom non-invasive echocardiographic measurement of myocardial work is obtained.

Secondary

MeasureTime frameDescription
measurement of myocardial by cardiac ultrasound norepinephrine administrationthrough study completion, an average of 1 yearThe measurement of myocardial work will be performed non-invasively by cardiac ultrasound. The secondary outcomes will be assess the impact of norepinephrine administration on the different components of myocardial work. as follows: (i) norepinephrine-induced changes in the different components of myocardial work, (ii) concordance between changes in myocardial work and changes in cardiac output induced by norepinephrine and (iii), the ability of the different components of myocardial work to predict fluid responsiveness.
measurement of myocardial by cardiac ultrasound during fluid administrationthrough study completion, an average of 1 yearThe measurement of myocardial work will be performed non-invasively by cardiac ultrasound. The secondary outcomes will be assess the impact of fluid administration on the different components of myocardial work. as follows: (i) fluid-induced changes in the different components of myocardial work, (ii) concordance between changes in myocardial work and changes in cardiac output induced by fluid administration (iii), the ability of the different components of myocardial work to predict fluid responsiveness.

Countries

France

Contacts

Primary ContactMathieu Jozwiak, MD
jozwiak.m@chu-nice.fr+33492035510

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026